Aerosolized Surfactant: What Is the Cost of Avoiding Intubation?
| Autor: | Anish Pillai, Nandkishor Kabra, Richa Choubey |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Novel technique
Biological Products Respiratory Distress Syndrome Respiratory distress business.industry medicine.medical_treatment Infant Newborn respiratory system Clinical trial Surface-Active Agents 03 medical and health sciences Aerosol delivery 0302 clinical medicine Pulmonary surfactant 030225 pediatrics Multicenter trial Anesthesia Pediatrics Perinatology and Child Health Intubation Intratracheal Humans Medicine Intubation business Aerosolization |
| Zdroj: | Pediatrics. 147 |
| ISSN: | 1098-4275 0031-4005 |
| DOI: | 10.1542/peds.2020-047985a |
| Popis: | We read, with great interest, the pragmatic multicenter trial on aerosolized surfactant presented by the Aero-O2 study investigators.1 This is the largest clinical trial evaluating the efficacy of aerosolized surfactant for preterm infants with respiratory distress syndrome (RDS) and adds to the recent data reported by CureNeb study team.2 We would like to congratulate the investigators for introducing a novel technique of delivering aerosolized surfactant using an interface resembling a pacifier. This ensures continuous aerosol delivery without loss of positive end-expiratory pressure. However, we would … E-mail: richachoubey2008{at}gmail.com |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|